General
Risperdal, IVC Filters, Xarelto lawsuits
The number of cases filed for Risperdal, IVC Filters, Xarelto lawsuits is increasing as the days…
Daiichi Sankyo Offers $300 Million to Settle Benicar Lawsuits
The Plaintiffs of Benicar MDL 2606 have been offered a settlement amount of $300 million by Daiichi Sankyo. If a 95% agreement is reached at by all the claimants, the settlement procedure will be finalized for the 2,300 cases filed under the…
The FDA Asks Bayer To Submit Problems Linked With Essure
Last week, the U.S. Food and Drug Administration (FDA) issued a letter to Bayer indicating requirements for submitting adverse event reports and postmarket activities associated with …
Risperdal Plaintiffs Allowed To Claim Punitive Damages
Defendants named in the Risperdal gynecomastia litigation, Johnson & Johnson, and its Janssen Pharmaceuticals subsidiary, will now have to compensate thousands of Risperdal…
Philadelphia too, proves to be unlucky for Xarelto Plaintiff
Just when Xarelto plaintiff attorneys were rejoicing and preparing on the lines of the first Philadelphia Xarelto trial which brought in the first-ever win for the…
An Appeal Submitted To Retain a $72 Million Talcum Verdict
The Johnson & Johnson’s Talcum powder case in which the verdict of $72 million was dismissed in October 2017 was put forth for an appeal by the family of the plaintiff, an Alabama woman who developed ovarian cancer due to the long-term use of…
MCL Status Requested For Abilify Cases Filed in New Jersey
A request has been put before the New Jersey Supreme Court by both parties of Abilify litigation for the creation of a Multicounty Litigation (MCL) to ensure that future…
Despite Its First TRT Trial Win, Auxilium Opts To Settle
Despite winning its first trial in November 2017, Testim gel makers, Auxilium, settled a lawsuit for an undisclosed amount, just days before the trial in Pennsylvania’s Philadelphia Court of Common Pleas. Allegations put forth by the…
No Ban On Transvaginal Mesh Devices So Far By FDA
The FDA has shown no signs or indications regarding any ban on transvaginal mesh devices used to treat pelvic organ prolapse (POP) and stress urinary…
Xarelto Makers’ Hopes Squashed A Second Time
Portola Pharmaceuticals received news of a second-time delay from the U.S. Food & Drug Administration (FDA) regarding the approval of AndexXa, an antidote developed to monitor uncontrollable bleeding linked to Xarelto and Eliquis.…